PTG-300 for Patients with Hereditary Hemochromatosis
Español  |  中國傳統的  |  简体中文
Call us  (855) 528-7322
Main Menu

PTG-300 for Patients with Hereditary Hemochromatosis

Sponsor: Protagonist Therapeutics, Inc

Protocol PTG-300-06: Open-label Study of PTG-300 in Subjects with Hereditary Hemochromatosis.